Use of the Medipee platform for digital automatic urine analysis in patients with urolithiasis for personalized stone metaphylaxis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00023326

Enrollment

Registered

2020-10-13

Start date

2020-09-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N20-N23

Interventions

Group 1: After consenting to participate in the study, all patients will receive standardized written information on stone metaphylaxis for the respective stone type. After personal instruction in the

Eligibility

Sex/Gender

All

Age

18 Years to 74 Years

Inclusion criteria

Inclusion criteria: - Patients with urolithiasis - All types of stone - Women and men = 18 and = 75 years - Regular use of your own smartphone (Android or iOS device) including apps - Domestic WC with Medipee-compatible design

Exclusion criteria

Exclusion criteria: - Patients without initial or recurrent urolithiasis - Women and men 75 years - Patients without their own smartphone (Android or iOS device) - Patients who do not use their smartphone including apps regularly or only for making phone calls - Domestic WC without Medipee-compatible design - Patients who have withdrawn their consent to participate in the study or have not given their consent to participate in the study

Design outcomes

Primary

Measure	Time frame
The primary aim is to check whether the Medipee devices are technically reliable in measuring and recording specific gravity and urine pH and in giving it back to the patient via the corresponding app. In addition, it is to be investigated whether patients accept the device and the app and are able to use them well in everyday life ("usability").	—

Secondary

Measure	Time frame
As secondary objectives, the micturition behavior of the test persons and a possible change of the urine parameters and thus a possible influence on the metaphylaxis in the course of the test will be recorded.	—

Countries

Germany

Contacts

Public ContactAlexander Winter

Universitätsklinik für Urologie, Klinikum Oldenburg, Fakultät für Medizin und Gesundheitswissenschaften, Carl von Ossietzky Universität Oldenburg

winter.alexander@klinikum-oldenburg.de04414032302

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026